Bayesian designs with frequentist and Bayesian error rate considerations
From MaRDI portal
Recommendations
- Control of type I error rates in Bayesian sequential designs
- Bayesian two-stage design for phase II clinical trials with switching hypothesis tests
- Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints
- A Bayesian Approach to the Design of Phase II Clinical Trials
- Bayesian designs and the control of frequentist characteristics: a practical solution
Cites work
Cited in
(8)- Control of type I error rates in Bayesian sequential designs
- A Bayesian model of design imperfections in online feedback systems and their relative impacts
- Bayesian designs and the control of frequentist characteristics: a practical solution
- Bayesian enhancement two-stage design with error control for phase II clinical trials
- Frequentist test in Bayesian two-stage designs applied in experimental trials
- Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints
- Bayesian two-stage design for phase II clinical trials with switching hypothesis tests
- A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach
This page was built for publication: Bayesian designs with frequentist and Bayesian error rate considerations
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5424966)